KPV

Overview

KPV is a synthetic tripeptide composed of lysine, proline, and valine, derived from the C-terminal fragment of the alpha-melanocyte-stimulating hormone (α-MSH). It is studied exclusively under non-clinical laboratory conditions for its potential role in cellular signaling, barrier protection, and inflammatory pathway regulation. Research involving KPV focuses on molecular mechanisms related to epithelial cell stability, cytokine modulation, and peptide-mediated anti-inflammatory signaling within controlled experimental settings.

Specifications

• Unit Size: 10 mg per vial

• Form: Lyophilized powder

• Storage: Store dry at 2 °C–8 °C. After reconstitution, refrigerate at 2 °C–8 °C and use within 10–14 days.

• Documentation: Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS) available upon request.

Research Context

Preclinical and in vitro studies have explored KPV in relation to:

• Modulation of inflammatory signaling pathways and cytokine expression

• Investigation of melanocortin receptor interactions and peptide signaling

• Cellular protection models involving oxidative and environmental stress

• Barrier integrity and epithelial homeostasis mechanisms under controlled assay conditions

All findings are derived from laboratory-based models and are not indicative of safety or efficacy in humans or animals.

Intended Use / Restrictions

• For laboratory research use only

• Not for human or veterinary use

• Not a drug, dietary supplement, or medical device

• Purchaser must be a qualified researcher or institution and is responsible for lawful handling and compliance with all applicable regulations.

Important Notice

The information provided is intended for scientific and educational purposes only. No claims are made regarding the safety, effectiveness, or suitability of this material for any form of human or veterinary administration. Buyers must ensure proper storage, handling, and disposal in accordance with institutional biosafety standards.